磷酸西他列汀
磷酸西他列汀
化学
二肽基肽酶-4
二肽基肽酶
二肽基肽酶-4抑制剂
酶抑制剂
沙沙利汀
口服活性
酶
药理学
生物化学
前药
立体化学
组合化学
体外
内分泌学
糖尿病
2型糖尿病
2型糖尿病
医学
作者
Dooseop Kim,Jennifer E. Kowalchick,Scott D. Edmondson,Anthony Mastracchio,Jinyou Xu,George J. Eiermann,Barbara Leiting,Joseph K. Wu,KellyAnn D. Pryor,Reshma A. Patel,Huaibing He,Kathryn A. Lyons,Nancy A. Thornberry,Ann E. Weber
标识
DOI:10.1016/j.bmcl.2007.03.098
摘要
A series of β-aminoamides bearing triazolopiperazines has been prepared and evaluated as potent, selective, orally active dipeptidyl peptidase IV (DPP-4) inhibitors. Efforts at optimization of the β-aminoamide series, which ultimately led to the discovery of JANUVIA™ (sitagliptin phosphate, compound 1), are described.
科研通智能强力驱动
Strongly Powered by AbleSci AI